Table 1. Clinical and pathologic characteristics of the patients.
Characteristic | Value | ||
---|---|---|---|
No. of patients | 132 | ||
No. of PZ nodules | 134 | ||
Clinical characteristics* | Benign lesions** (n = 80) | Malignant lesions (n = 54) | p value |
Age (y) | 65.9 ± 9.0 | 67.1 ± 10.8 | 0.475 |
PSA (ng/ml) | 5.2 ± 3.0 | 5.9 ± 3.1 | 0.211 |
Prostate volume (cm3) | 50.1 ± 26.5 | 43.3 ± 13.1 | 0.206 |
Gleason score |
No. of lesions, n (%) |
||
5 | 4 (7.4) | ||
6 | 19 (35.2) | ||
7 | 21 (38.9) | ||
8 | 7 (13.0) | ||
9 | 3 (5.5) |
PZ: peripheral zone, PSA: prostate-specific antigen.
*Data are shown as the mean ± standard deviation.
**Benign: 76, benign prostatic hyperplasia; 4, chronic prostatitis.